申请人:Warner-Lambert Company
公开号:US04771055A1
公开(公告)日:1988-09-13
Novel, orally active antibacterial agents are described and characterized as 7-[[3-(aminomethyl)-3-alkyl]-1-pyrrolidinyl]-6-fluoro-1,4-dihydro-4-oxo -3-quinoline carboxylic acids or corresponding 1,8-naphthyridine derivatives as well as methods for their manufacture.
描述和表征了一种新型口服活性抗菌剂,其为7-[[3-(氨甲基)-3-烷基]-1-吡咯啉基]-6-氟-1,4-二氢-4-氧基-3-喹啉羧酸或相应的1,8-萘啶衍生物,并提供了它们的制备方法。